Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
This research study is being done to collect regular and routine follow-up information related to the outcome of treatment for prostate cancer.
This study is also being done to relate treatment outcome to measurement of substances in the blood such as prostate-specific antigen (PSA) and other markers. Also environmental and genetic factors that might be responsible for prostate cancer are being investigated.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up|
Blood, urine, prostate tissue
|Study Start Date:||February 2010|
|Study Completion Date:||November 2012|
|Primary Completion Date:||November 2012 (Final data collection date for primary outcome measure)|
|High-risk radical prostatectomy patients|
|Primary external beam radiotherapy patients|
|Primary prostate brachytherapy patients|
|Hormone refractory prostate cancer patients|
|Prostate biopsy patients|